Sands Capital Ventures, LLC Top Holdings and 13F Report (2026) About Sands Capital Ventures, LLCInvestment ActivitySands Capital Ventures, LLC has $613.55 million in total holdings as of June 30, 2026.Sands Capital Ventures, LLC owns shares of 24 different stocks, but just 10 companies or ETFs make up 80% of its holdings.Approximately 26.72% of the portfolio was purchased this quarter.About 0.45% of the portfolio was sold this quarter.This quarter, Sands Capital Ventures, LLC has purchased 21 new stocks and bought additional shares in 10 stocks.Sands Capital Ventures, LLC sold shares of 2 stocks and completely divested from 0 stocks this quarter.Largest Holdings ALAMAR BIOSCIENCES INC $114,615,785NU $94,788,559KLAVIYO INC $59,315,005BETA BIONICS INC $58,105,034SPYGLASS PHARMA INC $55,650,267 Largest New Holdings this Quarter 010911105 - ALAMAR BIOSCIENCES INC $114,615,785 Holding67613T104 - ODYSSEY THERAPEUTICS INC $16,371,250 Holding15675D103 - CEREBRAS SYSTEMS INC $7,254,325 Holding Largest Purchases this Quarter ALAMAR BIOSCIENCES INC 4,230,926 shares (about $114.62M)ODYSSEY THERAPEUTICS INC 875,000 shares (about $16.37M)NU 557,183 shares (about $7.44M)CEREBRAS SYSTEMS INC 32,825 shares (about $7.25M)Coupang 317,223 shares (about $5.51M) Largest Sales this Quarter Samsara 44,629 shares (about $1.45M)Datadog 4,942 shares (about $1.29M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSands Capital Ventures, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorALAMAR BIOSCIENCES INC$114,615,785$114,615,785 â–²New Holding4,230,92618.7%COMMON STOCKNUNU$94,788,559$7,443,965 â–²8.5%7,094,95215.4%FinanceKLAVIYO INC$59,315,005$4,204,867 â–²7.6%3,928,1469.7%COM SER ABETA BIONICS INC$58,105,0340.0%3,708,0439.5%COMSPYGLASS PHARMA INC$55,650,2670.0%2,500,0129.1%COM SHSINHIBIKASE THERAPEUTICS INC$26,428,4990.0%13,018,9654.3%COM NEWDOORDASH INC$23,539,016$3,013,559 â–²14.7%127,5623.8%CL ACPNGCoupang$23,090,184$5,510,163 â–²31.3%1,329,3143.8%Consumer DiscretionaryDDOGDatadog$21,050,366$1,286,699 â–¼-5.8%80,8513.4%TechnologyBIOAGE LABS INC$19,273,5120.0%786,3533.1%COMTXG10x Genomics$18,471,0620.0%481,7703.0%HealthcareIOTSamsara$16,722,789$1,447,318 â–¼-8.0%515,6582.7%TechnologyODYSSEY THERAPEUTICS INC$16,371,250$16,371,250 â–²New Holding875,0002.7%COMMON STOCKTOSTToast$10,150,934$1,759,114 â–²21.0%364,8791.7%FinanceABOSAcumen Pharmaceuticals$9,932,6800.0%3,720,1051.6%HealthcareSERVICETITAN INC$7,675,217$1,321,499 â–²20.8%108,5451.3%SHS CL ACEREBRAS SYSTEMS INC$7,254,325$7,254,325 â–²New Holding32,8251.2%COM CL ASNOWSnowflake$6,234,741$1,080,353 â–²21.0%24,4981.0%TechnologyMNDYmonday.com$5,934,677$1,021,712 â–²20.8%81,9821.0%TechnologyTARSTarsus Pharmaceuticals$5,349,9000.0%85,0000.9%HealthcareTSHATaysha Gene Therapies$4,936,3850.0%724,8730.8%HealthcareCADLCandel Therapeutics$4,180,1210.0%405,8370.7%HealthcareACRVAcrivon Therapeutics$4,074,902$296,665 â–²7.9%2,289,2710.7%HealthcareFIGMA INC$400,965$70,171 â–²21.2%22,1650.1%CLASS A COM STKShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
